Skip to main content
. 2020 Dec 17;6(2):437–448. doi: 10.1016/j.ekir.2020.11.039

Figure 3.

Figure 3

Renin-angiotensin-aldosterone system inhibitor prescription according to Kidney Disease: Improving Global Outcomes recommendations for use in patients with chronic kidney disease with or without diabetes, by country. A2, Albuminuria 30-300 mg/g; A3, albuminuria >300 mg/g; ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blockers.